0000945621-22-000372.txt : 20221031 0000945621-22-000372.hdr.sgml : 20221031 20221031165150 ACCESSION NUMBER: 0000945621-22-000372 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221031 DATE AS OF CHANGE: 20221031 EFFECTIVENESS DATE: 20221031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Duet BioTherapeutics Inc. CENTRAL INDEX KEY: 0001952143 IRS NUMBER: 863309212 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-463398 FILM NUMBER: 221346823 BUSINESS ADDRESS: STREET 1: 251 SOUTH LAKE AVENUE STREET 2: SUITE 800 CITY: PASADENA STATE: CA ZIP: 91101 BUSINESS PHONE: 626-214-8082 MAIL ADDRESS: STREET 1: 251 SOUTH LAKE AVENUE STREET 2: SUITE 800 CITY: PASADENA STATE: CA ZIP: 91101 D 1 primary_doc.xml X0708 D LIVE 0001952143 Duet BioTherapeutics Inc. 251 SOUTH LAKE AVENUE SUITE 800 PASADENA CA CALIFORNIA 91101 626-214-8082 DELAWARE Olimmune Inc. None Corporation true 2021 Alan Horsager 251 South Lake Avenue Suite 800 Pasadena CA CALIFORNIA 91101 Executive Officer Director Ira Scott Greenspan 420 Lexington Avenue Suite 300 New York NY NEW YORK 10170 Director Raphael Hofstein 420 Lexington Avenue Suite 300 New York NY NEW YORK 10170 Director Robert J. Gibson 420 Lexington Avenue Suite 300 New York NY NEW YORK 10170 Director Joshua Lamstein 420 Lexington Avenue Suite 300 New York NY NEW YORK 10170 Director Biotechnology Decline to Disclose 06b false 2022-10-14 false true true true false 0 Indefinite 229873 Indefinite false 17 0 0 0 false Duet BioTherapeutics Inc. Robert J. Gibson Robert J. Gibson Director 2022-10-31